POSTER SESSION V
Wednesday, March 5, 2008   9:30 AM - 12:00 Noon
Convention Center Exhibit Hall A
Click on the blue numbers in parentheses to display abstracts.
Click the button next to any title to add to Itinerary Planner...
GYNECOLOGIC PATHOLOGY
Poster#
Title and Authors
Itinerary Planner
141
Ovarian Atypical Endometriosis: Its Close Association with Malignant Epithelial Tumors
(935)
M Fukunaga - Jikei University Daisan Hospital, Komaeshi, Tokyo, Japan
Ovarian Cancer Associated with Endometriosis Carries an Improved Prognosis
(892)
H Arabi, S Bandyopadhyay, D Thirabanjasak, A Munkarah, V Schimp, R Morris, R Ali-Fehmi - Wayne State University, Detroit, MI
EGFR and Her-2 Expression and Gene Amplification in Ovarian Tumors
(959)
H Kim, A Kim, HK Kim, I Kim - Korea University Medical College, Seoul, Republic of Korea
Cytokeratin 17 Expression in Non-Mucinous Carcinomas of the Ovary
(972)
A Malpica, MT Deavers, E Euscher - The University of Texas MD Anderson Cancer Center, Houston, TX
A Clinicopathologic Analysis of Primary Mucinous Adenocarcinoma of the Ovary in South Korea
(917)
G Choi, HI Lee, K-R Kim, SJ Robboy - University of Ulsan College of Medicine, Seoul, Republic of Korea; Dankook University Hospital, Cheonan-si, Republic of Korea; Duke University Medical Center, Durham
Occult Metastatic Breast Carcinoma and Its Morphologic Mimics in Risk Reducing Salpingo-Oophorectomies in Women with Breast Cancer
(902)
MJ Barnes, BB Crawford, CB Powell, L Chen, CJ Zaloudek, JT Rabban - UCSF, San Francisco
The Role of Cytokeratin 17 in the Distinction of Primary from Metastatic Mucinous Tumors of the Ovary
(926)
ED Euscher, MT Deavers, A Malpica - M.D. Anderson Cancer Center, Houston, TX
Ovarian Carcinoid Tumors of Primary Versus Metastatic Origin: Pitfalls in Diagnostic Use of the Intestinal Marker CDX-2
(1004)
JT Rabban, MF Lerwill, WG McCluggage, JP Grenert, CJ Zaloudek - UCSF, San Francisco; Massachusetts General Hospital, Boston; Royal Group of Hospitals Trust, Belfast, United Kingdom
Distinguishing Breast Carcinoma from Mullerian Serous Carcioma with Mammaglobin and Mesothelin
(957)
WA Kanner, MT Galgano, MH Stoler, SE Mills, KA Atkins - University of Virginia, Charlottesville, VA
Use of PAX-2 Antibody To Distinguish Metastatic Ovarian Serous Papillary Carcinoma from Primary Breast Carcinoma
(986)
SM O'Connor, R Bhargava, R Karabakhtsian, DJ Dabbs, M Chivukula - Magee Womens Hospital at University of Pittsburgh Medical Center, Pittsburgh, PA; University of Kentucky, Lexington, KY
Expression of PAX8 as a Useful Marker in the Differential Diagnosis of Ovarian and Mammary Carcinomas
(983)
D Nonaka, L Chiriboga, RA Soslow - New York University School of Medicine, New York, NY; Memorial Sloan-Kettering Cancer Center, New York, NY
A Molecular Genetic Approach Using Array Comparative Genomic Hybridization Analysis in Distinguishing Synchronous Versus Metastatic Carcinoma Arising Concurrently in the Ovary and the Endometrium
(1005)
H Rai, O Kunle, S Lele, P Mhawech-Fauceglia - Roswell Park Cancer Institute, Buffalo, NY
The Extracellular Portion of the MUC16 Cytoplasmic Domain Is Detectable in Ovarian Carcinoma Using a Novel Monoclonal Antibody, 4H11
(994)
KJ Park, RA Soslow, I Linkov, D Thapi, D Spriggs - Memorial Sloan-Kettering Cancer Center, New York, NY
Ovarian Cancer Associated T Cell Coinhibitory B7-H3 and B7x
(1049)
X Zang, RA Soslow, R Waitz, VE Reuter, A Wilton, HT Thaler, M Arul, SF Slovin, J Wei, J Dupont, JP Allison - Ludwig Center of Cancer Immunotherapy, New York; Memorial Sloan-Kettering Cancer Center, New York
Co-Regulated Levels of PIK3CA, PTEN and AKT mRNA in Ovarian Carcinomas
(1013)
M Romero-Sanchez, L Catasus, S Hyer, A Gallardo, I Gich, J Prat - Hospital de la Santa Creu i Sant Pau. Autonomous University of Barcelona, Barcelona, Spain
Overexpression of Insulin-Like Growth Factor Receptor 1 Is Associated with Poor Outcomes in Epithelial Ovarian Tumors
(1014)
JS Ross, A Glazyrin, DM Jones, CE Sheehan, JJ Xiong - Albany Medical College, Albany, NY
Microcystic Stromal Tumor of the Ovary: Report of 12 Cases of a Hitherto Uncharacterized Distinctive Ovarian Neoplasm
(946)
JA Irving, RH Young - Royal Jubilee Hospital, Victoria, Canada; Massachusetts General Hospital, Boston
Comparative Immunohistochemical Analysis of Various Sex Cord-Stromal Markers in Different Categories of Ovarian Sex Cord-Stromal Tumors
(1051)
C Zhao, TN Vinh, K McManus, D Dabbs, R Vang - Magee-Womens Hospital, UPMC, Pittsburgh, PA; AFIP, Washington, DC; Johns Hopkins Hospital, Baltimore, MD
SF1 Is Diagnostically Useful and Comparable to Other Sex Cord-Stromal Tumor Immunohistochemical Markers for the Differential Diagnosis of Ovarian Sertoli Cell Tumor
(1052)
C Zhao, TN Vinh, K McManus, D Dabbs, R Vang - Magee-Womens Hospital, University of Pittsburgh, Pittsburgh, PA; Armed Forces Institute of Pathology, Washington, DC; Johns Hopkins Hospital, Baltimore, MD
Comparative Analysis of CD 56, Calretinin, and Inhibin Immunohistochemical Staining in the Diagnosis of Ovarian Granulosa Cell Tumors
(948)
PA Jani, D El Demellawy - Thunder Bay Regional Health Science Centre, Thunder Bay, ON, Canada
Down-Regulation of MIR-195 and MIR-497 from the MicroRNA Cluster at Chromosome 17p13.1 in Papillary Serous Carcinoma of the Peritoneum
(932)
RJ Flavin, P Smyth, M Ring, S Russell, A Laios, S O'Toole, J Li, K Denning, S Aherne, C Martin, B Sheppard, K Lao, O Sheils, JJ O'Leary - Trinity College, Dublin, Ireland; Applied Biosystems, Foster City, CA
Immunophenotyping of Serous Carcinoma of the Female Genital Tract
(982)
S Nofech-Mozes, MA Khalifa, N Ismiil, RS Saad, Z Ghorab - Sunnybrook Health Sciences Centre, Toronto, Canada
Differential Microrna Expression in Primary Peritoneal Serous Carcinoma Versus Ovarian Serous Carcinoma
(987)
JJ O'Leary, P Smyth, A Laios, S O'Toole, S Russell, J Li, K Denning, S Aherne, M Ring, C Martin, B Sheppard, K Lao, O Sheils, RJ Flavin - Trinity College, Dublin, Ireland; Applied Biosystems, Foster City, CA
Is Retrograde Menstruation the Source of Endometriosis?
(1039)
OE Vele, MM Shevchuk, M daSilva - Lenox Hill Hospital, New York City, NY; Genzyme, Los Angeles, CA
Clinico-Pathologic Features of Female Genital Tract Neuroendocrine Carcinoma: A Series Study of 25 Cases from Two Institutes
(912)
A Chan, W Bshara, K Odunsi, T Pejovic, P Mhawech-Fauceglia - Roswell Park Cancer Ins, Buffalo, NY; Oregon Health & Science Univ, Portland, OR